Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fully automated centrifugal microfluidic system for self-calibrating isothermal nucleic acid quantification.

Biosensors & bioelectronics·2026
Same author

Enhancing Next-Generation Sequencing Sensitivity with High-Recovery Adapter Ligation and Cas9-Mediated Dimer Elimination.

Clinical chemistry·2026
Same author

Discovery of a New Tetrahydroquinoline-Based Chemotype for STING Inhibition with In Vivo Efficacy against Acute Kidney Injury.

Journal of medicinal chemistry·2026
Same author

Ultrafast and real-time on-chip quantitative polymerase chain reaction (ROC-qPCR) with sequence-specific signaling.

Analytica chimica acta·2026
Same author

Dual-Gated G-Quadruplex DNAzyme-LAMP for Sequence-Specific and Positive Colorimetric Nucleic Acid Detection.

ACS sensors·2026
Same author

B cell-reactive neoantigens boost antitumor immunity.

Science advances·2025
Same journal

Analyses of dextroamphetamine and its metabolites in human urine by capillary electrophoresis with diode array and capacitively coupled contactless conductivity detection (CE-DAD-C<sup>4</sup>D).

Analytical and bioanalytical chemistry·2026
Same journal

Whole-body mass spectrometry imaging reveals metabolome and lipid peroxidation heterogeneity in zebrafish xenografts of esophageal squamous cell carcinoma.

Analytical and bioanalytical chemistry·2026
Same journal

A robust and validated method for the determination of 21 urinary metabolites of 15 plasticizers, including phthalates, DEHTP, and DINCH, by online SPE and liquid chromatography-tandem mass spectrometry.

Analytical and bioanalytical chemistry·2026
Same journal

A label-free membrane-based biosensor array with AuNP-modified PDMS for sensitive and specific detection of alpha-fetoprotein.

Analytical and bioanalytical chemistry·2026
Same journal

Smartphone-integrated one-step colorimetric glucose detection at physiological pH enabled by a haloperoxidase mimic.

Analytical and bioanalytical chemistry·2026
Same journal

Chemiluminescence functionalized magnetic nanoparticles-based biosensor for sensitive detection of glucose, uric acid, and cholesterol.

Analytical and bioanalytical chemistry·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Microarray-based detection of Korean-specific BRCA1 mutations.

Cheulhee Jung1, Seong-Chun Yim, Dae-Yeon Cho

  • 1Department of Chemical and Biomolecular Engineering, KAIST, 373-1 Guseong-dong, Yuseong-gu, Daejeon, 305-701, Republic of Korea.

Analytical and Bioanalytical Chemistry
|March 29, 2008
PubMed
Summary
This summary is machine-generated.

This study introduces a reliable DNA microarray method for detecting breast cancer gene (BRCA1) mutations. The assay uses single base extension and zip-code microarrays for accurate genetic mutation diagnosis.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Related Experiment Videos

Last Updated: Jul 6, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Accurate detection of genetic mutations in genes like BRCA1 is crucial for breast cancer diagnosis and risk assessment.
  • Existing methods for mutation detection can be complex and may lack the multiplexing capability required for comprehensive screening.

Purpose of the Study:

  • To develop and validate a reliable multiplex assay for detecting human genetic mutations in the BRCA1 gene.
  • To establish a DNA microarray-based system for efficient and accurate genotyping of BRCA1 mutation sites.

Main Methods:

  • Utilized multiplex PCR to amplify genomic regions containing BRCA1 mutation sites.
  • Employed multiplex single base extension (SBE) reactions with bifunctional primers containing zip sequences.
  • Hybridized SBE products to zip-code microarrays followed by streptavidin-Cy3 staining for genotyping.

Main Results:

  • Successfully developed a multiplex assay for detecting human genetic mutations in the BRCA1 gene.
  • Demonstrated reliable genotyping of wild-type and heterozygote mutant BRCA1 samples.
  • Validated the efficacy of zip-code microarrays and SBE reactions for mutation detection.

Conclusions:

  • A reliable DNA microarray-based system for the diagnosis of human genetic mutations, specifically in BRCA1, has been developed.
  • The described multiplex assay offers a promising tool for genetic mutation detection and breast cancer susceptibility gene analysis.